PRUNE1 and NME/NDPK family proteins influence energy metabolism and signaling in cancer metastases.

D’Angelo, A., et al. (2004). Prune cAMP phosphodiesterase binds nm23-H1 and promotes cancer metastasis. Cancer Cell, 5(2), 137–149.

pubmed: 14998490 doi: 10.1016/S1535-6108(04)00021-2

Tammenkoski, M., et al. (2008). Human metastasis regulator protein H-prune is a short-chain exopolyphosphatase. Biochemistry, 47(36), 9707–9713.

pubmed: 18700747 doi: 10.1021/bi8010847

Diana, D., et al. (2013). Mapping functional interaction sites of human prune C-terminal domain by NMR spectroscopy in human cell lysates. Chemistry, 19(37), 12217–12220.

pubmed: 23939913 doi: 10.1002/chem.201302168

Carotenuto, M., et al. (2014). H-Prune through GSK-3β interaction sustains canonical WNT/β-catenin signaling enhancing cancer progression in NSCLC. Oncotarget, 5(14), 5736–5749.

pubmed: 25026278 pmcid: 4170634 doi: 10.18632/oncotarget.2169

Muller, T., et al. (2010). ASAP1 promotes tumor cell motility and invasiveness, stimulates metastasis formation in vivo, and correlates with poor survival in colorectal cancer patients. Oncogene, 29(16), 2393–2403.

pubmed: 20154719 doi: 10.1038/onc.2010.6

Zollo, M., et al. (2017). PRUNE is crucial for normal brain development and mutated in microcephaly with neurodevelopmental impairment. Brain, 140(4), 940–952.

pubmed: 28334956 pmcid: 5382943 doi: 10.1093/brain/awx014

Ferrucci, V., et al. (2018). Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-beta-OTX2-SNAIL via PTEN inhibition. Brain, 141(5), 1300–1319.

pubmed: 29490009 doi: 10.1093/brain/awy039

Ferrucci, V., et al. (2021). Prune-1 drives polarization of tumor-associated macrophages (TAMs) within the lung metastatic niche in triple-negative breast cancer. IScience, 24(1), 101938.

pubmed: 33426510 doi: 10.1016/j.isci.2020.101938

Khan, I., & Steeg, P. S. (2018). The relationship of NM23 (NME) metastasis suppressor histidine phosphorylation to its nucleoside diphosphate kinase, histidine protein kinase and motility suppression activities. Oncotarget, 9(12), 10185–10202.

pubmed: 29535799 doi: 10.18632/oncotarget.23796

Morera, S., et al. (1994). Adenosine 5’-diphosphate binding and the active site of nucleoside diphosphate kinase. Biochemistry, 33(2), 459–467.

Postel, E. H., et al. (2000). Human NM23/nucleoside diphosphate kinase regulates gene expression through DNA binding to nuclease-hypersensitive transcriptional elements. Journal of Bioenergetics and Biomembranes, 32(3), 277–284.

pubmed: 11768311 doi: 10.1023/A:1005541114029

Sharma, S., Sengupta, A., & Chowdhury, S. (2018). NM23/NDPK proteins in transcription regulatory functions and chromatin modulation: Emerging trends. Laboratory Investigation, 98(2), 175–181.

pubmed: 29083410 doi: 10.1038/labinvest.2017.98

Lombardi, D., et al. (2001). Interplay between the antimetastatic nm23 and the retinoblastoma-related Rb2/p130 genes in promoting neuronal differentiation of PC12 cells. Cell Death and Differentiation, 8(5), 470–476.

pubmed: 11423907 doi: 10.1038/sj.cdd.4400842

Carotenuto, M., et al. (2013). Neuroblastoma tumorigenesis is regulated through the Nm23-H1/h-Prune C-terminal interaction. Science and Reports, 3, 1351.

doi: 10.1038/srep01351

Nambu, J., et al. (2016). h-Prune affects anaplastic thyroid cancer invasion and metastasis. Oncology Reports, 35(6), 3445–3452.

pubmed: 27109060 doi: 10.3892/or.2016.4759

Noguchi, T., et al. (2009). h-Prune is an independent prognostic marker for survival in esophageal squamous cell carcinoma. Annals of Surgical Oncology, 16(5), 1390–1396.

pubmed: 17896143 doi: 10.1245/s10434-007-9585-3

Oue, N., et al. (2007). Increased expression of h-prune is associated with tumor progression and poor survival in gastric cancer. Cancer Science, 98(8), 1198–1205.

pubmed: 17532757 doi: 10.1111/j.1349-7006.2007.00515.x

Hashimoto, M., et al. (2016). h-Prune is associated with poor prognosis and epithelial-mesenchymal transition in patients with colorectal liver metastases. International Journal of Cancer, 139(4), 812–823.

pubmed: 27037526 doi: 10.1002/ijc.30118

Xu, J., et al. (2023). PRUNE1 (located on chromosome 1q213) promotes multiple myeloma with 1q21 Gain by enhancing the links between purine and mitochondrion. Br J Haematol, 203(4), 599–613.

pubmed: 37666675 doi: 10.1111/bjh.19088

Marino, N., et al. (2012). Insights into the biology and prevention of tumor metastasis provided by the Nm23 metastasis suppressor gene. Cancer and Metastasis Reviews, 31(3–4), 593–603.

pubmed: 22706779 doi: 10.1007/s10555-012-9374-8

Boissan, M., et al. (2005). Increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma. Journal of the National Cancer Institute, 97(11), 836–845.

pubmed: 15928304 doi: 10.1093/jnci/dji143

Boissan, M., et al. (2010). Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells. Cancer Research, 70(19), 7710–7722.

pubmed: 20841469 doi: 10.1158/0008-5472.CAN-10-1887

Tan, C. Y., & Chang, C. L. (2018). NDPKA is not just a metastasis suppressor - be aware of its metastasis-promoting role in neuroblastoma. Laboratory Investigation, 98(2), 219–227.

pubmed: 28991262 doi: 10.1038/labinvest.2017.105

Galasso, A., & Zollo, M. (2009). The Nm23-H1-h-Prune complex in cellular physiology: A “tip of the iceberg” protein network perspective. Molecular and Cellular Biochemistry, 329(1–2), 149–159.

Bibbo, F., et al. (2021). Functional Genomics of PRUNE1 in neurodevelopmental disorders (NDDs) tied to medulloblastoma (MB) and other tumors. Frontiers in Oncology, 11, 758146.

pubmed: 34745995 pmcid: 8569853 doi: 10.3389/fonc.2021.758146

Vlatkovic, N., Chang, S. H., & Boyd, M. T. (2015). Janus-faces of NME-oncoprotein interactions. Naunyn-Schmiedeberg’s Archives of Pharmacology, 388(2), 175–187.

Sturtevant, A. H. (1956). A highly specific complementary lethal system in Drosophila melanogaster. Genetics, 41(1), 118–123.

pubmed: 17247604 pmcid: 1209758 doi: 10.1093/genetics/41.1.118

Timmons, L., & Shearn, A. (1996). Germline transformation using a prune cDNA rescues prune/killer of prune lethality and the prune eye color phenotype in Drosophila. Genetics, 144(4), 1589–1600.

pubmed: 8978047 pmcid: 1207711 doi: 10.1093/genetics/144.4.1589

Teng, D. H., Engele, C. M., & Venkatesh, T. R. (1991). A product of the prune locus of Drosophila is similar to mammalian GTPase-activating protein. Nature, 353(6343), 437–440.

pubmed: 1654526 doi: 10.1038/353437a0

Carotenuto, P., et al. (2006). PRUNE and NM23-M1 expression in embryonic and adult mouse brain. Journal of Bioenergetics and Biomembranes, 38(3–4), 233–246.

pubmed: 17033939 doi: 10.1007/s10863-006-9044-z

Bilitou, A., et al. (2012). Spatial and temporal expressions of prune reveal a role in Muller gliogenesis during Xenopus retinal development. Gene, 509(1), 93–103.

pubmed: 22967741 doi: 10.1016/j.gene.2012.08.001

Garzia, L., et al. (2008). Phosphorylation of nm23-H1 by CKI induces its complex formation with h-prune and promotes cell motility. Oncogene, 27(13), 1853–1864.

pubmed: 17906697 doi: 10.1038/sj.onc.1210822

Ferrucci, V., et al. (2018). A competitive cell-permeable peptide impairs Nme-1 (NDPK-A) and Prune-1 interaction: Therapeutic applications in cancer. Laboratory Investigation, 98(5), 571–581.

pubmed: 29449633 doi: 10.1038/s41374-017-0011-6

Srivastava A, Nagai T, Srivastava A, Miyashita O, Tama F (2018) Role of computational methods in going beyond Xray Crystallography to explore protein structure and dynamics. International Journal of Molecular Sciences, 19(11), 3401. https://doi.org/10.3390/ijms19113401

Nussinov, R., et al. (2022). AlphaFold, artificial intelligence (AI), and allostery. The Journal of Physical Chemistry B, 126(34), 6372–6383.

pubmed: 35976160 pmcid: 9442638 doi: 10.1021/acs.jpcb.2c04346

Boissan, M., et al. (2009). The mammalian Nm23/NDPK family: From metastasis control to cilia movement. Molecular and Cellular Biochemistry, 329(1–2), 51–62.

pubmed: 19387795 doi: 10.1007/s11010-009-0120-7

Adam K, Ning J, Reina J, Hunter T (2020) NME/NM23/NDPK and Histidine Phosphorylation. International Journal of Molecular Sciences, 21(16), 5848. https://doi.org/10.3390/ijms21165848

Sievers, F., et al. (2011). Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Molecular Systems Biology, 7, 539.

pubmed: 21988835 pmcid: 3261699 doi: 10.1038/msb.2011.75

Gouet, P., Robert, X., & Courcelle, E. (2003). ESPript/ENDscript: Extracting and rendering sequence and 3D information from atomic structures of proteins. Nucleic Acids Research, 31(13), 3320–3323.

pubmed: 12824317 pmcid: 168963 doi: 10.1093/nar/gkg556

Morera, S., et al. (1995). X-ray structure of human nucleoside diphosphate kinase B complexed with GDP at 2 A resolution. Structure, 3(12), 1307–1314.

pubmed: 8747457 doi: 10.1016/S0969-2126(01)00268-4

Webb, P. A., et al. (1995). The crystal structure of a human nucleoside diphosphate kinase, NM23-H2. Journal of Molecular Biology, 251(4), 574–587.

pubmed: 7658474 doi: 10.1006/jmbi.1995.0457

Min, K., et al. (2002). Crystal structure of human nucleoside diphosphate kinase A, a metastasis suppressor. Proteins, 46(3), 340–342.

pubmed: 11835509 doi: 10.1002/prot.10038

Milon, L., et al. (2000). The human nm23-H4 gene product is a mitochondrial nucleoside diphosphate kinase. Journal of Biological Chemistry, 275(19), 14264–14272.

pubmed: 10799505 doi: 10.1074/jbc.275.19.14264

Georgescauld F, Song Y, Dautant A (2020) Structure, Folding and Stability of Nucleoside Diphosphate Kinases. International Journal of Molecular Sciences, 21(18), 6779. https://doi.org/10.3390/ijms21186779

Senior, A. W., et al. (2020). Improved protein structure prediction using potentials from deep learning. Nature, 577(7792), 706–710.

pubmed: 31942072 doi: 10.1038/s41586-019-1923-7

Chang, C. L., et al. (1994). Nm23-H1 mutation in neuroblastoma. Nature, 370(6488), 335–336.

pubmed: 8047138 doi: 10.1038/370335a0

Lascu, I., et al. (1997). A point mutation of human nucleoside diphosphate kinase A found in aggressive neuroblastoma affects protein folding. Journal of Biological Chemistry, 272(25), 15599–15602.

pubmed: 9188446 doi: 10.1074/jbc.272.25.15599

Georgescauld, F., et al. (2011). Aggregation of the neuroblastoma-associated mutant (S120G) of the human nucleoside diphosphate kinase-A/NM23-H1 into amyloid fibrils. Naunyn-Schmiedeberg’s Archives of Pharmacology, 384(4–5), 373–381.

Mocan, I., et al. (2007). Protein phosphorylation corrects the folding defect of the neuroblastoma (S120G) mutant of human nucleoside diphosphate kinase A/Nm23-H1. The Biochemical Journal, 403(1), 149–156.

pubmed: 17155928 pmcid: 1828887 doi: 10.1042/BJ20061141

Chen, Y., et al. (2010). A Cys/Ser mutation of NDPK-A stabilizes its oligomerization state and enhances its activity. Journal of Biochemistry, 148(2), 149–155.

pubmed: 20403806 doi: 10.1093/jb/mvq041

Gilles, A. M., et al. (1991). Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. J Biol Chem, 266(14), 8784–9.

pubmed: 1851158 doi: 10.1016/S0021-9258(18)31515-1

Potel, C. M., Fasci, D., & Heck, A. J. R. (2018). Mix and match of the tumor metastasis suppressor Nm23 protein isoforms in vitro and in vivo. FEBS Journal, 285(15), 2856–2868.

pubmed: 29863788 doi: 10.1111/febs.14525

Erent, M., et al. (2001). Structural and catalytic properties and homology modelling of the human nucleoside diphosphate kinase C, product of the DRnm23 gene. European Journal of Biochemistry, 268(7), 1972–1981.

pubmed: 11277919 doi: 10.1046/j.1432-1327.2001.2076.doc.x

Abu-Taha, I. H., et al. (2017). Nucleoside diphosphate kinase-C suppresses cAMP formation in human heart failure. Circulation, 135(9), 881–897.

pubmed: 27927712 doi: 10.1161/CIRCULATIONAHA.116.022852

Khan, I., Gril, B., & Steeg, P. S. (2019). Metastasis suppressors NME1 and NME2 promote dynamin 2 oligomerization and regulate tumor cell endocytosis, motility, and metastasis. Cancer Research, 79(18), 4689–4702.

pubmed: 31311812 pmcid: 8288561 doi: 10.1158/0008-5472.CAN-19-0492

Boissan, M., Schlattner, U., & Lacombe, M. L. (2018). The NDPK/NME superfamily: State of the art. Laboratory Investigation, 98(2), 164–174.

pubmed: 29451272 doi: 10.1038/labinvest.2017.137

Chen CW, Tsao N, Zhang W, Chang ZF (2020) NME3 Regulates Mitochondria to Reduce ROS-Mediated Genome Instability. International Journal of Molecular Sciences, 21(14), 5048. https://doi.org/10.3390/ijms21145048

Boyer, P. D., et al. (1962). Identification of phosphohistidine in digests from a probable intermediate of oxidative phosphorylation. Journal of Biological Chemistry, 237(10), PC3306–PC3308.

pubmed: 14014715 doi: 10.1016/S0021-9258(18)50167-8

Tokarska-Schlattner, M., et al. (2008). The nucleoside diphosphate kinase D (NM23-H4) binds the inner mitochondrial membrane with high affinity to cardiolipin and couples nucleotide transfer with respiration. Journal of Biological Chemistry, 283(38), 26198–26207.

pubmed: 18635542 pmcid: 3258864 doi: 10.1074/jbc.M803132200

Yu, B. Y. K., et al. (2021). Regulation of metastasis suppressor NME1 by a key metabolic cofactor coenzyme A. Redox Biology, 44, 101978.

pubmed: 33903070 pmcid: 8212152 doi: 10.1016/j.redox.2021.101978

Chen, W., et al. (2015). The ubiquitin E3 ligase SCF-FBXO24 recognizes deacetylated nucleoside diphosphate kinase A to enhance its degradation. Molecular and Cellular Biology, 35(6), 1001–1013.

pubmed: 25582197 pmcid: 4333090 doi: 10.1128/MCB.01185-14

Fujita, Y., et al. (2015). Acetylation of NDPK-D regulates its subcellular localization and cell survival. PLoS ONE, 10(10), e0139616.

pubmed: 26426123 pmcid: 4591271 doi: 10.1371/journal.pone.0139616

Kagan, V. E., et al. (2016). NDPK-D (NM23-H4)-mediated externalization of cardiolipin enables elimination of depolarized mitochondria by mitophagy. Cell Death and Differentiation, 23(7), 1140–1151.

pubmed: 26742431 pmcid: 4946882 doi: 10.1038/cdd.2015.160

Song, E. J., et al. (2000). Oxidative modification of nucleoside diphosphate kinase and its identification by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Biochemistry, 39(33), 10090–10097.

pubmed: 10955997 doi: 10.1021/bi000267a

Tossounian MA, Baczynska M, Dalton W, Newell C, Ma Y, Das S, Semelak JA, Estrin DA, Filonenko V, Trujillo M, Peak-Chew SY, Skehel M, Fraternali F, Orengo C, Gout I (2022) Profiling the Site of Protein CoAlation and Coenzyme A Stabilization Interactions. Antioxidants (Basel), 11(7):1362. https://doi.org/10.3390/antiox11071362

Snider, N. T., Altshuler, P. J., & Omary, M. B. (2015). Modulation of cytoskeletal dynamics by mammalian nucleoside diphosphate kinase (NDPK) proteins. Naunyn-Schmiedeberg’s Archives of Pharmacology, 388(2), 189–197.

Puts, G. S., et al. (2018). Nuclear functions of NME proteins. Laboratory Investigation, 98(2), 211–218.

pubmed: 29058704 doi: 10.1038/labinvest.2017.109

Yadav, V. K., et al. (2014). Promoter-proximal transcription factor binding is transcriptionally active when coupled with nucleosome repositioning in immediate vicinity. Nucleic Acids Research, 42(15), 9602–9611.

pubmed: 25081206 pmcid: 4150765 doi: 10.1093/nar/gku596

Rayner, K., et al. (2008). Discovery of NM23-H2 as an estrogen receptor beta-associated protein: Role in estrogen-induced gene transcription and cell migration. Journal of Steroid Biochemistry and Molecular Biology, 108(1–2), 72–81.

pubmed: 17964137 doi: 10.1016/j.jsbmb.2007.07.006

Choudhuri, T., et al. (2010). Nm23-H1 can induce cell cycle arrest and apoptosis in B cells. Cancer Biology & Therapy, 9(12), 1065–1078.

doi: 10.4161/cbt.9.12.11995

Yoon, J. H., et al. (2005). Characterization of the 3’ –> 5’ exonuclease activity found in human nucleoside diphosphate kinase 1 (NDK1) and several of its homologues. Biochemistry, 44(48), 15774–15786.

Kaetzel, D. M., et al. (2006). Potential roles of 3’-5’ exonuclease activity of NM23-H1 in DNA repair and malignant progression. Journal of Bioenergetics and Biomembranes, 38(3–4), 163–167.

Samejima, I., et al. (2022). Mapping the invisible chromatin transactions of prophase chromosome remodeling. Mol Cell, 82(3), 696-708 e4.

pubmed: 35090599 pmcid: 8823707 doi: 10.1016/j.molcel.2021.12.039

Romani, P., et al. (2018). Extracellular NME proteins: A player or a bystander? Laboratory Investigation, 98(2), 248–257.

pubmed: 29035383 doi: 10.1038/labinvest.2017.102

Otero-Estevez, O., et al. (2016). Evaluation of serum nucleoside diphosphate kinase A for the detection of colorectal cancer. Science and Reports, 6, 26703.

doi: 10.1038/srep26703

Duan S, Nordmeier S, Byrnes AE, Buxton ILO (2021) Extracellular vesicle-mediated purinergic signaling contributes to host microenvironment plasticity and metastasis in triple negative breast cancer. International Journal of Molecular Sciences, 22(2):597. https://doi.org/10.3390/ijms22020597

Prentice, K. J., et al. (2021). A hormone complex of FABP4 and nucleoside kinases regulates islet function. Nature, 600(7890), 720–726.

pubmed: 34880500 pmcid: 8983123 doi: 10.1038/s41586-021-04137-3

Maiolino, M., et al. (2019). Inorganic polyphosphate regulates AMPA and NMDA receptors and protects against glutamate excitotoxicity via activation of P2Y receptors. Journal of Neuroscience, 39(31), 6038–6048.

pubmed: 31147524 doi: 10.1523/JNEUROSCI.0314-19.2019

Freije, J. M., et al. (1997). Site-directed mutation of Nm23-H1. Mutations lacking motility suppressive capacity upon transfection are deficient in histidine-dependent protein phosphotransferase pathways in vitro. J Biol Chem, 272(9), 5525–32.

pubmed: 9038158 doi: 10.1074/jbc.272.9.5525

Wieland, T. (2007). Interaction of nucleoside diphosphate kinase B with heterotrimeric G protein betagamma dimers: Consequences on G protein activation and stability. Naunyn-Schmiedeberg’s Archives of Pharmacology, 374(5–6), 373–383.

MacDonald, N. J., et al. (1996). Site-directed mutagenesis of nm23-H1. Mutation of proline 96 or serine 120 abrogates its motility inhibitory activity upon transfection into human breast carcinoma cells. J Biol Chem, 271(41), 25107–16.

pubmed: 8810265 doi: 10.1074/jbc.271.41.25107

Kim, Y. I., et al. (2003). Point mutations affecting the oligomeric structure of Nm23-H1 abrogates its inhibitory activity on colonization and invasion of prostate cancer cells. Biochemical and Biophysical Research Communications, 307(2), 281–289.

pubmed: 12859952 doi: 10.1016/S0006-291X(03)01195-1

Zhou, Q., et al. (2007). Double mutant P96S/S120G of Nm23-H1 abrogates its NDPK activity and motility-suppressive ability. Biochemical and Biophysical Research Communications, 356(2), 348–353.

pubmed: 17335772 doi: 10.1016/j.bbrc.2007.02.066

MacDonald, N. J., et al. (1993). A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. Journal of Biological Chemistry, 268(34), 25780–25789.

pubmed: 8245015 doi: 10.1016/S0021-9258(19)74458-5

Gong, L., et al. (2013). Metastasis suppressor Nm23-H1 inhibits STAT3 signaling via a negative feedback mechanism. Biochemical and Biophysical Research Communications, 434(3), 541–546.

pubmed: 23583378 doi: 10.1016/j.bbrc.2013.03.110

Wu, Z., et al. (2017). Two serine residues of non-metastasis protein 23–H1 are critical in inhibiting signal transducer and activator of transcription 3 activity in human lung cancer cells. Oncology Letters, 14(2), 2475–2482.

pubmed: 28781685 pmcid: 5530184 doi: 10.3892/ol.2017.6363

Lee, E., et al. (2009). Multiple functions of Nm23-H1 are regulated by oxido-reduction system. PLoS ONE, 4(11), e7949.

pubmed: 19956735 pmcid: 2776532 doi: 10.1371/journal.pone.0007949

Zhang, S., et al. (2022). Long-chain fatty acyl coenzyme A inhibits NME1/2 and regulates cancer metastasis. Proc Natl Acad Sci U S A, 119(11), e2117013119.

pubmed: 35259022 pmcid: 8931372 doi: 10.1073/pnas.2117013119

Pennino, F. P., et al. (2021). The metastasis suppressor protein NM23-H1 modulates the PI3K-AKT axis through interaction with the p110alpha catalytic subunit. Oncogenesis, 10(4), 34.

pubmed: 33931587 pmcid: 8087825 doi: 10.1038/s41389-021-00326-x

Lacombe, M. L., et al. (2021). The mitochondrially-localized nucleoside diphosphate kinase D (NME4) is a novel metastasis suppressor. BMC Biology, 19(1), 228.

pubmed: 34674701 pmcid: 8529772 doi: 10.1186/s12915-021-01155-5

Wu, H., et al. (2020). Comprehensive analysis of the NME gene family functions in breast cancer. Transl Cancer Res, 9(10), 6369–6382.

pubmed: 35117245 pmcid: 8798044 doi: 10.21037/tcr-20-1712

Zollo, M., et al. (2005). Overexpression of h-prune in breast cancer is correlated with advanced disease status. Clinical Cancer Research, 11(1), 199–205.

pubmed: 15671547 doi: 10.1158/1078-0432.199.11.1

Kristensson MA (2021) The game of tubulins. Cells, 10(4), 745. https://doi.org/10.3390/cells10040745

Kimura, N., & Shimada, N. (1990). Evidence for complex formation between GTP binding protein(Gs) and membrane-associated nucleoside diphosphate kinase. Biochemical and Biophysical Research Communications, 168(1), 99–106.

pubmed: 2158321 doi: 10.1016/0006-291X(90)91680-Q

Wieland, T., & Jakobs, K. H. (1989). Receptor-regulated formation of GTP[gamma S] with subsequent persistent Gs-protein activation in membranes of human platelets. FEBS Letters, 245(1–2), 189–193.

pubmed: 2494072 doi: 10.1016/0014-5793(89)80219-4

Wieland, T., & Jakobs, K. H. (1992). Evidence for nucleoside diphosphokinase-dependent channeling of guanosine 5’-(gamma-thio)triphosphate to guanine nucleotide-binding proteins. Molecular Pharmacology, 42(5), 731–735.

Cuello, F., et al. (2003). Activation of heterotrimeric G proteins by a high energy phosphate transfer via nucleoside diphosphate kinase (NDPK) B and Gbeta subunits Complex formation of NDPK B with Gbeta gamma dimers and phosphorylation of His-266 IN Gbeta. J Biol Chem, 278(9), 7220–6.

pubmed: 12486123 doi: 10.1074/jbc.M210304200

Hippe, H. J., et al. (2003). Activation of heterotrimeric G proteins by a high energy phosphate transfer via nucleoside diphosphate kinase (NDPK) B and Gbeta subunits Specific activation of Gsalpha by an NDPK B.Gbetagamma complex in H10 cells. J Biol Chem., 278(9), 7227–33.

pubmed: 12486122 doi: 10.1074/jbc.M210305200

Fuhs, S. R., et al. (2015). Monoclonal 1- and 3-phosphohistidine antibodies: New tools to study histidine phosphorylation. Cell, 162(1), 198–210.

pubmed: 26140597 pmcid: 4491144 doi: 10.1016/j.cell.2015.05.046

Hippe, H. J., et al. (2007). Regulation of cardiac cAMP synthesis and contractility by nucleoside diphosphate kinase B/G protein beta gamma dimer complexes. Circulation Research, 100(8), 1191–1199.

pubmed: 17363702 doi: 10.1161/01.RES.0000264058.28808.cc

Hippe, H. J., et al. (2003). Activation of heterotrimeric G proteins by a high energy phosphate transfer via nucleoside diphosphate kinase (NDPK) B and Gβ subunits Specific activation of Gsα by an NDPK B Gβγ complex in H10 cells. J Biol Chem, 278(9), 7227–33.

pubmed: 12486122 doi: 10.1074/jbc.M210305200

Sakai, Y., et al. (2022). Histidine dephosphorylation of the Gbeta protein GPB-1 promotes axon regeneration in C elegans. EMBO Rep, 23(12), e55076.

pubmed: 36278516 pmcid: 9724660 doi: 10.15252/embr.202255076

Arang, N., & Gutkind, J. S. (2020). G Protein-coupled receptors and heterotrimeric G proteins as cancer drivers. FEBS Letters, 594(24), 4201–4232.

pubmed: 33270228 pmcid: 8849590 doi: 10.1002/1873-3468.14017

Wu, V., et al. (2019). Illuminating the Onco-GPCRome: Novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy. Journal of Biological Chemistry, 294(29), 11062–11086.

pubmed: 31171722 pmcid: 6643028 doi: 10.1074/jbc.REV119.005601

McDermott, W. G., et al. (2008). Nm23-H1 homologs suppress tumor cell motility and anchorage independent growth. Clinical & Experimental Metastasis, 25(2), 131–138.

doi: 10.1007/s10585-007-9128-0

Qu, L., et al. (2013). Inhibitory effect of upregulated DR-nm23 expression on invasion and metastasis in colorectal cancer. European Journal of Cancer Prevention, 22(6), 512–522.

pubmed: 23765094 doi: 10.1097/CEJ.0b013e328361625d

Boissan, M., et al. (2014). Membrane trafficking. Nucleoside diphosphate kinases fuel dynamin superfamily proteins with GTP for membrane remodeling. Science, 344(6191), 1510–5.

pubmed: 24970086 pmcid: 4601533 doi: 10.1126/science.1253768

Prunier C, Chavrier P, Boissan M (2023) Mechanisms of action of NME metastasis suppressors - a family affair. Cancer Metastasis Rev, 42(4), 1155–1167. https://doi.org/10.1007/s10555-023-10118-x

Khan, I., & Steeg, P. S. (2021). Endocytosis: A pivotal pathway for regulating metastasis. British Journal of Cancer, 124(1), 66–75.

pubmed: 33262521 doi: 10.1038/s41416-020-01179-8

Colicelli J (2004) Human RAS superfamily proteins and related GTPases. Sci STKE, 2004(250), RE13. https://doi.org/10.1126/stke.2502004re13

Otsuki, Y., et al. (2001). Tumor metastasis suppressor nm23H1 regulates Rac1 GTPase by interaction with Tiam1. Proc Natl Acad Sci U S A, 98(8), 4385–4390.

pubmed: 11274357 pmcid: 31844 doi: 10.1073/pnas.071411598

Zhu, J., et al. (1999). Interaction of the Ras-related protein associated with diabetes rad and the putative tumor metastasis suppressor NM23 provides a novel mechanism of GTPase regulation. Proc Natl Acad Sci U S A, 96(26), 14911–14918.

pubmed: 10611312 pmcid: 24747 doi: 10.1073/pnas.96.26.14911

Otero, A. S. (2000). NM23/nucleoside diphosphate kinase and signal transduction. Journal of Bioenergetics and Biomembranes, 32(3), 269–275.

pubmed: 11768310 doi: 10.1023/A:1005589029959

Palacios, F., et al. (2002). ARF6-GTP recruits Nm23-H1 to facilitate dynamin-mediated endocytosis during adherens junctions disassembly. Nature Cell Biology, 4(12), 929–936.

pubmed: 12447393 doi: 10.1038/ncb881

Cormier, K. W., et al. (2023). Interactomes of glycogen synthase kinase-3 isoforms. Journal of Proteome Research, 22(3), 977–989.

pubmed: 36779422 pmcid: 9990120 doi: 10.1021/acs.jproteome.2c00825

McKay, M. M., & Morrison, D. K. (2007). Integrating signals from RTKs to ERK/MAPK. Oncogene, 26(22), 3113–3121.

pubmed: 17496910 doi: 10.1038/sj.onc.1210394

Kortum, R. L., & Lewis, R. E. (2004). The molecular scaffold KSR1 regulates the proliferative and oncogenic potential of cells. Molecular and Cellular Biology, 24(10), 4407–4416.

pubmed: 15121859 pmcid: 400485 doi: 10.1128/MCB.24.10.4407-4416.2004

Müller, J., et al. (2001). C-TAK1 regulates Ras signaling by phosphorylating the MAPK scaffold, KSR1. Molecular Cell, 8(5), 983–993.

pubmed: 11741534 doi: 10.1016/S1097-2765(01)00383-5

Ory, S., et al. (2003). Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites. Current Biology, 13(16), 1356–1364.

pubmed: 12932319 doi: 10.1016/S0960-9822(03)00535-9

Hartsough, M. T., et al. (2002). Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway. Journal of Biological Chemistry, 277(35), 32389–32399.

pubmed: 12105213 doi: 10.1074/jbc.M203115200

Baghban, R., et al. (2020). Tumor microenvironment complexity and therapeutic implications at a glance. Cell Communication and Signaling: CCS, 18(1), 59.

pubmed: 32264958 pmcid: 7140346 doi: 10.1186/s12964-020-0530-4

Spano, D., & Zollo, M. (2012). Tumor microenvironment: A main actor in the metastasis process. Clinical & Experimental Metastasis, 29(4), 381–395.

doi: 10.1007/s10585-012-9457-5

Spano, D., et al. (2012). Molecular networks that regulate cancer metastasis. Seminars in Cancer Biology, 22(3), 234–249.

pubmed: 22484561 doi: 10.1016/j.semcancer.2012.03.006

Anderson, N. M., & Simon, M. C. (2020). The tumor microenvironment. Current Biology, 30(16), R921–R925.

pubmed: 32810447 doi: 10.1016/j.cub.2020.06.081

Maimela, N. R., Liu, S., & Zhang, Y. (2019). Fates of CD8+ T cells in tumor microenvironment. Computational and Structural Biotechnology Journal, 17, 1–13.

pubmed: 30581539 doi: 10.1016/j.csbj.2018.11.004

Plitas, G., et al. (2016). Regulatory T cells exhibit distinct features in human breast cancer. Immunity, 45(5), 1122–1134.

pubmed: 27851913 pmcid: 5134901 doi: 10.1016/j.immuni.2016.10.032

Melaiu, O., et al. (2019). Influence of the tumor microenvironment on NK cell function in solid tumors. Frontiers in Immunology, 10, 3038.

pubmed: 32038612 doi: 10.3389/fimmu.2019.03038

Sharonov, G. V., et al. (2020). B cells, plasma cells and antibody repertoires in the tumour microenvironment. Nature Reviews Immunology, 20(5), 294–307.

pubmed: 31988391 doi: 10.1038/s41577-019-0257-x

Zou, Z., et al. (2023). Tumor-associated macrophage polarization in the inflammatory tumor microenvironment. Frontiers in Oncology, 13, 1103149.

pubmed: 36816959 pmcid: 9934926 doi: 10.3389/fonc.2023.1103149

Giese, M. A., Hind, L. E., & Huttenlocher, A. (2019). Neutrophil plasticity in the tumor microenvironment. Blood, 133(20), 2159–2167.

pubmed: 30898857 pmcid: 6524564 doi: 10.1182/blood-2018-11-844548

Peng, X., et al. (2021). Metabolism of dendritic cells in tumor microenvironment: For immunotherapy. Frontiers in Immunology, 12, 613492.

pubmed: 33732237 pmcid: 7959811 doi: 10.3389/fimmu.2021.613492

Li, K., et al. (2021). Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer. Signal Transduction and Targeted Therapy, 6(1), 362.

pubmed: 34620838 pmcid: 8497485 doi: 10.1038/s41392-021-00670-9

Trova, S., et al. (2023). Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3-inflammasome activation. PLoS ONE, 18(7), e0288162.

pubmed: 37418424 pmcid: 10328239 doi: 10.1371/journal.pone.0288162

Cai, Z., et al. (2011). Activation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth. Cancer Research, 71(7), 2466–2475.

pubmed: 21427357 pmcid: 3074302 doi: 10.1158/0008-5472.CAN-10-1993

Flentie, K., et al. (2018). Nucleoside diphosphate kinase-3 (NME3) enhances TLR5-induced NFkappaB activation. Molecular Cancer Research, 16(6), 986–999.

pubmed: 29523766 doi: 10.1158/1541-7786.MCR-17-0603

You, D. J., et al. (2014). A splicing variant of NME1 negatively regulates NF-kappaB signaling and inhibits cancer metastasis by interacting with IKKbeta. Journal of Biological Chemistry, 289(25), 17709–17720.

pubmed: 24811176 pmcid: 4067205 doi: 10.1074/jbc.M114.553552

Seong, H. A., Jung, H., & Ha, H. (2007). NM23-H1 tumor suppressor physically interacts with serine-threonine kinase receptor-associated protein, a transforming growth factor-beta (TGF-beta) receptor-interacting protein, and negatively regulates TGF-beta signaling. Journal of Biological Chemistry, 282(16), 12075–12096.

pubmed: 17314099 doi: 10.1074/jbc.M609832200

Chaudhuri, J., & Alt, F. W. (2004). Class-switch recombination: Interplay of transcription, DNA deamination and DNA repair. Nature Reviews Immunology, 4(7), 541–552.

pubmed: 15229473 doi: 10.1038/nri1395

Zheng, S., et al. (2019). NME proteins regulate class switch recombination. FEBS Letters, 593(1), 80–87.

pubmed: 30411342 doi: 10.1002/1873-3468.13290

Srivastava, S., et al. (2006). Phosphatidylinositol 3-phosphate indirectly activates KCa3.1 via 14 amino acids in the carboxy terminus of KCa3.1. Mol Biol Cell., 17(1), 146–54.

pubmed: 16251351 pmcid: 1345654 doi: 10.1091/mbc.e05-08-0763

Shi, X., et al. (2022). TGF-beta signaling in the tumor metabolic microenvironment and targeted therapies. Journal of Hematology & Oncology, 15(1), 135.

doi: 10.1186/s13045-022-01349-6

Liberti, M. V., & Locasale, J. W. (2016). The Warburg effect: How does it benefit cancer cells? Trends in Biochemical Sciences, 41(3), 211–218.

pubmed: 26778478 pmcid: 4783224 doi: 10.1016/j.tibs.2015.12.001

Zhu, J., & Thompson, C. B. (2019). Metabolic regulation of cell growth and proliferation. Nature Reviews Molecular Cell Biology, 20(7), 436–450.

pubmed: 30976106 pmcid: 6592760 doi: 10.1038/s41580-019-0123-5

Gupta, S., Roy, A., & Dwarakanath, B. S. (2017). Metabolic cooperation and competition in the tumor microenvironment: Implications for therapy. Frontiers in Oncology, 7, 68.

pubmed: 28447025 pmcid: 5388702 doi: 10.3389/fonc.2017.00068

Kim, J. W., et al. (2006). HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia. Cell Metabolism, 3(3), 177–185.

pubmed: 16517405 doi: 10.1016/j.cmet.2006.02.002

Wang, Y., et al. (2019). Coordinative metabolism of glutamine carbon and nitrogen in proliferating cancer cells under hypoxia. Nature Communications, 10(1), 201.

pubmed: 30643150 pmcid: 6331631 doi: 10.1038/s41467-018-08033-9

Huang, B., Song, B. L., & Xu, C. (2020). Cholesterol metabolism in cancer: Mechanisms and therapeutic opportunities. Nature Metabolism, 2(2), 132–141.

pubmed: 32694690 doi: 10.1038/s42255-020-0174-0

Hensley, C. T., Wasti, A. T., & DeBerardinis, R. J. (2013). Glutamine and cancer: Cell biology, physiology, and clinical opportunities. The Journal of Clinical Investigation, 123(9), 3678–3684.

pubmed: 23999442 pmcid: 3754270 doi: 10.1172/JCI69600

Lehuede, C., et al. (2016). Metabolic plasticity as a determinant of tumor growth and metastasis. Cancer Research, 76(18), 5201–5208.

pubmed: 27587539 doi: 10.1158/0008-5472.CAN-16-0266

Li, F., & Simon, M. C. (2020). Cancer cells don’t live alone: Metabolic communication within tumor microenvironments. Developmental Cell, 54(2), 183–195.

Mazzone, M., Menga, A., & Castegna, A. (2018). Metabolism and TAM functions-it takes two to tango. FEBS Journal, 285(4), 700–716.

pubmed: 29055087 doi: 10.1111/febs.14295

Chantranupong, L., et al. (2016). The CASTOR proteins are arginine sensors for the mTORC1 pathway. Cell, 165(1), 153–164.

pubmed: 26972053 pmcid: 4808398 doi: 10.1016/j.cell.2016.02.035

Rothhammer, V., & Quintana, F. J. (2019). The aryl hydrocarbon receptor: An environmental sensor integrating immune responses in health and disease. Nature Reviews Immunology, 19(3), 184–197.

pubmed: 30718831 doi: 10.1038/s41577-019-0125-8

Liu, Y., et al. (2018). Tumor-repopulating cells induce PD-1 expression in CD8(+) T cells by transferring kynurenine and AhR activation. Cancer Cell, 33(3), 480-494 e7.

pubmed: 29533786 doi: 10.1016/j.ccell.2018.02.005

Scharping, N. E., et al. (2021). Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion. Nature Immunology, 22(2), 205–215.

pubmed: 33398183 pmcid: 7971090 doi: 10.1038/s41590-020-00834-9

Watson, M. J., et al. (2021). Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature, 591(7851), 645–651.

pubmed: 33589820 pmcid: 7990682 doi: 10.1038/s41586-020-03045-2

Colegio, O. R., et al. (2014). Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature, 513(7519), 559–563.

pubmed: 25043024 pmcid: 4301845 doi: 10.1038/nature13490

Pan, M., et al. (2016). Regional glutamine deficiency in tumours promotes dedifferentiation through inhibition of histone demethylation. Nature Cell Biology, 18(10), 1090–1101.

pubmed: 27617932 pmcid: 5536113 doi: 10.1038/ncb3410

Arner, E. N., & Rathmell, J. C. (2023). Metabolic programming and immune suppression in the tumor microenvironment. Cancer Cell, 41(3), 421–433.

pubmed: 36801000 doi: 10.1016/j.ccell.2023.01.009

Wagner, P. D., & Vu, N. D. (1995). Phosphorylation of ATP-citrate lyase by nucleoside diphosphate kinase. Journal of Biological Chemistry, 270(37), 21758–21764.

pubmed: 7665595 doi: 10.1074/jbc.270.37.21758

Wagner, P. D., Steeg, P. S., & Vu, N. D. (1997). Two-component kinase-like activity of nm23 correlates with its motility-suppressing activity. Proc Natl Acad Sci U S A, 94(17), 9000–9005.

pubmed: 9256424 pmcid: 22999 doi: 10.1073/pnas.94.17.9000

Busam, R. D., et al. (2006). First structure of a eukaryotic phosphohistidine phosphatase. Journal of Biological Chemistry, 281(45), 33830–33834.

pubmed: 16990267 doi: 10.1074/jbc.C600231200

Klumpp, S., et al. (2003). ATP-citrate lyase as a substrate of protein histidine phosphatase in vertebrates. Biochemical and Biophysical Research Communications, 306(1), 110–115.

pubmed: 12788074 doi: 10.1016/S0006-291X(03)00920-3

Hindupur, S. K., et al. (2018). The protein histidine phosphatase LHPP is a tumour suppressor. Nature, 555(7698), 678–682.

pubmed: 29562234 pmcid: 6376988 doi: 10.1038/nature26140

Icard, P., et al. (2020). ATP citrate lyase: A central metabolic enzyme in cancer. Cancer Letters, 471, 125–134.

pubmed: 31830561 doi: 10.1016/j.canlet.2019.12.010

Zaidi, N., Swinnen, J. V., & Smans, K. (2012). ATP-citrate lyase: A key player in cancer metabolism. Cancer Research, 72(15), 3709–3714.

pubmed: 22787121 doi: 10.1158/0008-5472.CAN-11-4112

Johnson, J. D., et al. (1998). Genetic evidence for the expression of ATP- and GTP-specific succinyl-CoA synthetases in multicellular eucaryotes. Journal of Biological Chemistry, 273(42), 27580–27586.

pubmed: 9765291 doi: 10.1074/jbc.273.42.27580

Lambeth, D. O., et al. (2004). Expression of two succinyl-CoA synthetases with different nucleotide specificities in mammalian tissues. Journal of Biological Chemistry, 279(35), 36621–36624.

pubmed: 15234968 doi: 10.1074/jbc.M406884200

Yang, Y., & Gibson, G. E. (2019). Succinylation links metabolism to protein functions. Neurochemical Research, 44(10), 2346–2359.

pubmed: 30903449 pmcid: 6755074 doi: 10.1007/s11064-019-02780-x

Dai, X., et al. (2022). Succinylation and redox status in cancer cells. Frontiers in Oncology, 12, 1081712.

pubmed: 36605449 pmcid: 9807787 doi: 10.3389/fonc.2022.1081712

Lu, K., & Han, D. (2022). A review of the mechanism of succinylation in cancer. Medicine (Baltimore), 101(45), e31493.

pubmed: 36397343 doi: 10.1097/MD.0000000000031493

Luhtala, N., et al., Illuminating histidine phosphorylation in the pancreatic tumor microenvironment. bioRxiv, 2022: p. 2022.09.15.508158.

Wagner, P.D. and N.D. Vu, Histidine to aspartate phosphotransferase activity of nm23 proteins: Phosphorylation of aldolase C on Asp-319. Biochem J, 2000. 346 Pt 3(Pt 3): p. 623–30.

Pamidimukkala, N. V., et al. (2018). Metastasis suppressor NME1 directly activates transcription of the ALDOC gene in melanoma cells. Anticancer Research, 38(11), 6059–6068.

pubmed: 30396920 pmcid: 6367674 doi: 10.21873/anticanres.12956

Izraely, S., et al. (2021). The melanoma brain metastatic microenvironment: Aldolase C partakes in shaping the malignant phenotype of melanoma cells - a case of inter-tumor heterogeneity. Molecular Oncology, 15(5), 1376–1390.

pubmed: 33274599 doi: 10.1002/1878-0261.12872

Ernst O, Sun J, Lin B, Banoth B, Dorrington MG, Liang J, Schwarz B, Stromberg KA, Katz S, Vayttaden SJ, Bradfield CJ, Slepushkina N, Rice CM, Buehler E, Khillan JS, McVicar DW, Bosio CM, Bryant CE, Sutterwala FS, Martin SE, Lal-Nag M, Fraser IDC (2021) A genome-wide screen uncovers multiple roles for mitochondrial nucleoside diphosphate kinase D in inflammasome activation. Sci Signal, 14(694), eabe0387. https://doi.org/10.1126/scisignal.abe0387

Muller, W. E. G., Schroder, H. C., & Wang, X. (2019). Inorganic polyphosphates as storage for and generator of metabolic energy in the extracellular matrix. Chemical Reviews, 119(24), 12337–12374.

pubmed: 31738523 pmcid: 6935868 doi: 10.1021/acs.chemrev.9b00460

Müller, W. E. G., et al. (2023). The physiological polyphosphate as a healing biomaterial for chronic wounds: Crucial roles of its antibacterial and unique metabolic energy supplying properties. Journal of Materials Science & Technology, 135, 170–185.

doi: 10.1016/j.jmst.2022.07.018

Scoma ER, Da Costa RT, Leung HH, Urquiza P, Guitart-Mampel M, Hambardikar V, Riggs LM, Wong CO, Solesio ME. Human prune regulates the metabolism of mammalian inorganic polyphosphate and bioenergetics. International Journal of Molecular Sciences, 24(18), 13859. https://doi.org/10.3390/ijms241813859

Wang, Q., et al. (2010). Adenovirus-mediated delivery of nm23-H1 gene inhibits growth of colorectal carcinoma cell line Lovo. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, 27(6), 1332–1335.

pubmed: 21374989

Lim, J., et al. (2011). Cell-permeable NM23 blocks the maintenance and progression of established pulmonary metastasis. Cancer Research, 71(23), 7216–7225.

pubmed: 21987726 doi: 10.1158/0008-5472.CAN-11-2015

Palmieri, D., et al. (2005). Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer. Journal of the National Cancer Institute, 97(9), 632–642.

pubmed: 15870434 doi: 10.1093/jnci/dji111

Miller, K. D., et al. (2014). A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: Translational breast cancer research consortium trial 007. Breast Cancer Research and Treatment, 148(1), 99–106.

pubmed: 25257727 pmcid: 8374454 doi: 10.1007/s10549-014-3131-3

Lee, J. J., et al. (2018). Small molecule activator of Nm23/NDPK as an inhibitor of metastasis. Science and Reports, 8(1), 10909.

doi: 10.1038/s41598-018-29101-6

Carotenuto, M., et al. (2015). A therapeutic approach to treat prostate cancer by targeting Nm23-H1/h-Prune interaction. Naunyn-Schmiedeberg’s Archives of Pharmacology, 388(2), 257–269.

Asadzadeh, F., et al. (2017). In vivo bioluminescence imaging using orthotopic xenografts towards patient’s derived-xenograft Medulloblastoma models. The Quarterly Journal of Nuclear Medicine and Molecular Imaging, 61(1), 95–101.

Middelhaufe, S., et al. (2007). Domain mapping on the human metastasis regulator protein h-Prune reveals a C-terminal dimerization domain. The Biochemical Journal, 407(2), 199–205.

pubmed: 17655525 pmcid: 2049022 doi: 10.1042/BJ20070408

PRUNE1 and NME/NDPK family proteins influence energy metabolism and signaling in cancer metastases.

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Sous-ensembles de citation

Informations de copyright

Références

Auteurs

Veronica Ferrucci (V)

Santosh Lomada (S)

Thomas Wieland (T)

Massimo Zollo (M)

Classifications MeSH